echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Fujian tenth standard began dynamic adjustment: 634 product standard was affected, and the red line was broken. We should pay close attention to price reduction

    Fujian tenth standard began dynamic adjustment: 634 product standard was affected, and the red line was broken. We should pay close attention to price reduction

    • Last Update: 2019-12-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    City of Cantor Last night, Fujian pharmaceutical tendering issued a notice, according to the relevant requirements of the dynamic adjustment of the maximum sales price limit, to dynamically adjust the maximum sales price limit of some drugs with large price difference between the actual transaction price and the maximum sales price limit, and simultaneously adjust the medical insurance payment standard According to the notice, if the enterprises in the list need to adjust the online price, please put forward through the "online status and price adjustment" item in Fujian pharmaceutical machinery joint sunshine procurement platform According to the author's findings The price adjustment is based on the dynamic adjustment rules for sunshine purchase of joint price limit of drugs based on medical insurance payment settlement price in Fujian Province (mdyc [2018] No 11) After a brief analysis and statistics, the author found that the maximum sales price limit and medical insurance payment standard of some drugs (different manufacturers, the same common name, different dosage forms and the same specification) have been standardized Price reduction (as shown below) According to the sunshine purchase rules of Fujian Province, medical institutions shall bear the part higher than the maximum sales price; patients shall bear the part lower than the maximum sales price but higher than the medical insurance payment standard The difference between the purchase price (online price) and the sale price of drugs shall be attributed to the medical institution This basically means that if the online price is higher than the adjusted maximum sales price limit and the medical insurance payment standard, then it will step into the state of "red line hanging upside down" and face the situation of medical institutions not purchasing If the online price is still lower than or equal to the adjusted maximum sales price and medical insurance payment standard, it can still be purchased normally Due to the four price nested purchase mode adopted by Fujian sunshine, the provincial online (purchase) price is not open, so it is impossible to judge how many of the 634 product specifications have inadvertently broken into the red line However, as far as I know, since last night, many enterprises have called local medical institutions in Fujian to learn about the purchasing status of drugs after breaking into the red line According to Fujian sunshine purchase adjustment rules, once the drug enters the red line state, the only way is to actively reduce the price of the Internet and reduce it below the safety line Therefore, there is a relevant requirement in the notice that "if the enterprises in the list need to adjust the online price, please put forward it under the" online status and price adjustment "in Fujian pharmaceutical and machinery joint sunshine procurement platform" At this point, we might as well carefully sort out several price relations and the possibility of being collected of Fujian medicine bidding According to carefully reading the Fujian drug bidding plan and tracking the whole process of Fujian drug bidding, Fujian province implements the joint limited price sunshine procurement of drugs based on the payment and settlement price of medical insurance In fact, there are four prices, respectively: It is the ceiling price of medical institutions for external sales This price, in the context of Fujian's completion of Jiulong water control and establishment of provincial medical insurance office, is more given a special mission: that is, the maximum sales price limit is a force to balance the interests of both the medical supply and demand sides, and its existence is to strive to promote the mutual benefit and win-win of both the supply and demand sides.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.